Vassilev LT et al. reported that radiation-induced ataxia–telangiectasia mutated (ATM) and its target p53, which is a well-known modulator that enhances radioresistance in various cancers, may act as possible biomarkers of cervical cancer cell response to radiation treatment [33]. The gene discussed is TP53; the disease is cancer.